Health Care

'Pharma bro' Martin Shkreli heads into fraud trial

Jury selection is set to begin Monday in the federal securities-fraud trial of Martin Shkreli, the former pharmaceutical executive who rose to international infamy two years ago for his decision to dramatically raise the prices of lifesaving drugs